Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

765
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Microbial Biosensors01:17

Microbial Biosensors

88
Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...
88
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

56
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
56

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics, temporal trends and outcomes of Clostridioides difficile infection among hospitalized patients in Spain, 2016-2022.

BMC infectious diseases·2026
Same author

Chronic Obstructive Pulmonary Disease Hospitalization in Spain (2016-2023): Mortality Impact of Comorbidity, Sex-Based Disparities and the Impact of COVID-19.

Journal of personalized medicine·2026
Same author

Point-of-care ultrasound in tropical infections: Expanding frontline diagnostics.

Medicina clinica·2026
Same author

Pleural Empyema in Spain (2016-2022): A Nationwide Study on Trends in Hospitalizations, Mortality, and Impact of Comorbidities.

Journal of personalized medicine·2025
Same author

Novel Biomarkers for SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.

Journal of personalized medicine·2025
Same author

Biomarkers for SARS-CoV-2 infection. A narrative review.

Frontiers in medicine·2025

Related Experiment Video

Updated: Apr 30, 2026

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.7K

Biomarkers for sepsis.

Cesar Henriquez-Camacho1, Juan Losa1

  • 1Hospital Universitario Fundacion Alorcon, Calle Valdelaguna 1, 28922 Madrid, Spain.

Biomed Research International
|May 7, 2014
PubMed
Summary
This summary is machine-generated.

New biomarkers show promise for diagnosing bloodstream infections and sepsis, potentially improving upon current markers like procalcitonin (PCT) and C-reactive protein (CRP). These novel markers may offer better accuracy in identifying infections and guiding treatment decisions.

More Related Videos

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

598
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

1.8K

Related Experiment Videos

Last Updated: Apr 30, 2026

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.7K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

598
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

1.8K

Area of Science:

  • Infectious Diseases
  • Clinical Diagnostics
  • Biomarker Discovery

Background:

  • Bloodstream infections and sepsis are critical healthcare concerns due to high antibiotic use and rising antimicrobial resistance.
  • Current biomarkers such as procalcitonin (PCT) and C-reactive protein (CRP) have limitations in differentiating sepsis from other inflammatory conditions and predicting patient outcomes.
  • Accurate and timely diagnosis of bloodstream infections is essential for effective patient management and combating antimicrobial resistance.

Purpose of the Study:

  • To review and discuss emerging biomarkers for bloodstream infections and sepsis.
  • To evaluate the potential of novel biomarkers to overcome the limitations of existing diagnostic markers.
  • To explore biomarkers that can aid in distinguishing sepsis from non-infectious inflammatory states and predicting treatment response.

Main Methods:

  • Literature review of current and emerging biomarkers for bloodstream infections and sepsis.
  • Analysis of the diagnostic and prognostic capabilities of biomarkers including soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), soluble urokinase-type plasminogen receptor (suPAR), proadrenomedullin (ProADM), and presepsin.
  • Comparison of the performance of novel biomarkers against established markers like PCT and CRP.

Main Results:

  • Established biomarkers like PCT and CRP have demonstrated utility but possess significant limitations in specificity and predictive value for sepsis.
  • Emerging biomarkers such as sTREM-1, suPAR, ProADM, and presepsin show potential for improved accuracy in diagnosing bloodstream infections and sepsis.
  • These novel biomarkers may offer enhanced ability to differentiate infectious from non-infectious inflammation and guide antimicrobial therapy decisions.

Conclusions:

  • There is a critical need for improved biomarkers to accurately diagnose and manage bloodstream infections and sepsis.
  • Novel biomarkers like sTREM-1, suPAR, ProADM, and presepsin represent promising advancements in the field.
  • Further research and clinical validation are necessary to fully integrate these new biomarkers into routine clinical practice for sepsis management.